Chairs
- Isabelle L. Ray-Coquard (Lyon, CEDEX, France)
- Susana Banerjee (London, United Kingdom)
Introduction
Speakers
- Susana Banerjee (London, United Kingdom)
Do we still need radical surgery in the PARP inhibitor era?
Speakers
- Giovanni Scambia (Rome, Italy)
How to select the best first line maintenance treatment? Is molecular profiling the only criteria to choose?
Speakers
- Isabelle L. Ray-Coquard (Lyon, CEDEX, France)
New treatment in the current ovarian cancer beyond ADCs
Speakers
- Nicoletta Colombo (Milan, Italy)
PARP inhibitors: Mechanism of resistance and how to overcome
Speakers
- Iain McNeish (London, United Kingdom)